OncoTherapy Science, Inc. (4564.T)

JPY 26.0

(-3.7%)

Annual Cash Flows

(In JPY)
Breakdown 2024 2023 2022 2021 2020 2019
Operating Cash Flow -1.22 Billion -794.9 Million -2.07 Billion -1.76 Billion -2.27 Billion -2.37 Billion
Net Income -1.28 Billion -1.11 Billion -2.57 Billion -1.56 Billion -2.23 Billion -3.19 Billion
Depreciation & Amortization - - 16.54 Million 49 Million 39.74 Million 391.99 Million
Deferred income taxes - - 545.37 Million - - -
Stock-based compensation 7.65 Million 31.33 Million 39.38 Million - - -
Change in working capital -106.51 Million 339.75 Million -61.04 Million -175.12 Million -116.5 Million 165.04 Million
Other non-cash items 156.23 Million -49.56 Million -43.17 Million -76.5 Million 38.23 Million 264.18 Million
Investing Cash Flow -33.35 Million -20.31 Million -467.92 Million -52.22 Million -30.7 Million -74.2 Million
Investments in PPE -2.62 Million -5.39 Million -456.94 Million -43.91 Million -131.37 Million -71.34 Million
Acquisitions - 476 Thousand 49 Thousand 49 Thousand 102.7 Million -
Investment purchases - - - - - -
Sales/Maturities of investments - - - - - -
Other Investing Activities -30.72 Million -15.4 Million -11.02 Million -8.36 Million -2.02 Million -2.85 Million
Financing Cash Flow 671.36 Million 95.95 Million 1.47 Billion - 2.16 Billion 565.97 Million
Debt repayment -4.64 Million - - - - -
Dividends payments - - - - - -
Common Stock Repurchased -6.54 Million - - - - -
Common Stock Issuance 682.55 Million - 1.46 Billion - 2.16 Billion 553.95 Million
Other Financing Activities -2000.00 95.95 Million 12.25 Million - 2.16 Billion 12.01 Million
Accounts receivables -15.18 Million 276 Million -247 Million -123 Million -12 Million -16 Million
Accounts payables - - - - - -
Inventory 25.61 Million 131.42 Million -189.97 Million -16.13 Million 402 Thousand -10.77 Million
Other working capital -116.94 Million -67.67 Million 375.92 Million -35.98 Million -104.91 Million 191.81 Million
Cash at beginning of period 1.11 Billion 1.83 Billion 2.89 Billion 4.71 Billion 4.85 Billion 6.74 Billion
Cash at end of period 527.65 Million 1.11 Billion 1.83 Billion 2.89 Billion 4.71 Billion 4.85 Billion
Capital Expenditure -2.62 Million -5.39 Million -456.94 Million -43.91 Million -131.37 Million -71.34 Million
Effect of forex changes on cash - -1000.00 -1000.00 - -1.58 Million -903 Thousand
Net cash flow / Change in cash -589.97 Million -719.27 Million -1.06 Billion -1.81 Billion -143.72 Million -1.88 Billion
Free Cash Flow -1.23 Billion -800.29 Million -2.53 Billion -1.8 Billion -2.4 Billion -2.44 Billion

Cash Flow Charts